- Home
- FGL vs PULM Comparison
FGL vs PULM Comparison
Compare FGL & PULM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FGL
- PULM
- Stock Information
- Founded
- FGL 2021
- PULM 2003
- Country
- FGL Malaysia
- PULM United States
- Employees
- FGL N/A
- PULM N/A
- Industry
- FGL
- PULM Biotechnology: Pharmaceutical Preparations
- Sector
- FGL
- PULM Health Care
- Exchange
- FGL NYSE
- PULM Nasdaq
- Market Cap
- FGL 25.4M
- PULM 33.2M
- IPO Year
- FGL 2024
- PULM N/A
- Fundamental
- Price
- FGL $0.88
- PULM $6.38
- Analyst Decision
- FGL
- PULM
- Analyst Count
- FGL 0
- PULM 0
- Target Price
- FGL N/A
- PULM N/A
- AVG Volume (30 Days)
- FGL 1.3M
- PULM 59.3K
- Earning Date
- FGL 07-22-2025
- PULM 08-12-2025
- Dividend Yield
- FGL N/A
- PULM N/A
- EPS Growth
- FGL N/A
- PULM N/A
- EPS
- FGL N/A
- PULM N/A
- Revenue
- FGL $20,205,441.00
- PULM $1,921,000.00
- Revenue This Year
- FGL N/A
- PULM N/A
- Revenue Next Year
- FGL N/A
- PULM $134.88
- P/E Ratio
- FGL N/A
- PULM N/A
- Revenue Growth
- FGL N/A
- PULM N/A
- 52 Week Low
- FGL $0.66
- PULM $1.78
- 52 Week High
- FGL $5.26
- PULM $10.40
- Technical
- Relative Strength Index (RSI)
- FGL N/A
- PULM 39.53
- Support Level
- FGL N/A
- PULM $6.26
- Resistance Level
- FGL N/A
- PULM $6.96
- Average True Range (ATR)
- FGL 0.00
- PULM 0.85
- MACD
- FGL 0.00
- PULM -0.11
- Stochastic Oscillator
- FGL 0.00
- PULM 39.71
About FGL FOUNDER GROUP LTD
Founder Group Ltd is a solar solutions provider in Malaysia, offering end-to-end services for commercial and industrial sectors, as well as large-scale solar power projects, encompassing project design, engineering, and comprehensive project management. Its focus is on two key segments: large-scale solar projects and commercial and industrial (C&I) solar projects. Large-scale solar projects are utility scale solar PV power plants with installed generating capacity of 1 MWac or more. C&I projects are smaller scale solar projects where the solar PV systems are installed on rooftops and are designed to generate electricity for commercial and industrial properties for their own consumption, such as factories, warehouses and commercial stores. Its revenue is derived from Malaysia.
About PULM Pulmatrix Inc.
Pulmatrix Inc is a biopharmaceutical company that has focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE. Its pipeline of clinical assets includes PUR3100 for the treatment of acute migraine, PUR1800 for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and PUR1900 for the treatment of ABPA in patients with asthma and in patients with cystic fibrosis (CF).